{
    "title": "US approves Regeneron's antibody treatment for Ebola",
    "url": "https://www.dailymail.co.uk/wires/afp/article-8841603/US-approves-Regenerons-antibody-treatment-Ebola.html",
    "date": "2020-10-14",
    "keywords": [
        "drug",
        "inmazeb",
        "ebola",
        "virus",
        "fda",
        "rate",
        "mortality",
        "trial",
        "regeneron",
        "president",
        "protein",
        "half",
        "percent",
        "vaccine",
        "disease",
        "immune",
        "wednesday",
        "labmade",
        "antibody",
        "treatment",
        "biotech",
        "firm",
        "technology",
        "platform",
        "company",
        "therapy",
        "covid19",
        "trump",
        "coronavirus",
        "food",
        "administration",
        "commissioner",
        "stephen",
        "hahn",
        "action",
        "commitment",
        "health",
        "basis",
        "science",
        "mixture",
        "cocktail",
        "surface",
        "glycoprotein",
        "zaire",
        "ebolavirus",
        "george",
        "officer",
        "york",
        "adult",
        "study",
        "republic",
        "congo",
        "journal",
        "medicine",
        "side",
        "heart",
        "breathing",
        "infection",
        "time",
        "efficacy",
        "prevention",
        "december",
        "class",
        "cancer",
        "mice",
        "humanlike",
        "host",
        "lab",
        "masse"
    ],
    "category": [
        "wires",
        "afp"
    ]
}